Drawing for WIESLAB

USPTO serial 79043453

WIESLAB

Reviewed by CopyMark Law Group

Reg. 3547031Status 706Registered
Filing date
Status date
Registration date
Dec 16, 2008
Examiner
HELLMAN, ELI J
Law office
GENERIC WEB UPDATE

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with WIESLAB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kevin A. Thompson

Kevin A. Thompson Ladas & Parry LLP224 South Michigan AvenueSuite 1600Chicago, IL 60604

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic chemicals, namely, diagnostic preparations for scientific and research use, diagnostic preparations for scientific and research laboratory use, laboratory chemicals, namely, antibody reagents for detection in bodily fluid, blood, blood serum, cell and tissue analysis for in vitro diagnostic use, reagents for chemical analyses, diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology, assays for research purposesACTIVE—
005Chemical preparations for medical [ and veterinary ] purposes, namely, chemical reagents; chemical reagents for medical [ and veterinary ] purposes, clinical medical reagents, diagnostic preparations for medical purposes, diagnostic preparations for clinical or medical laboratory use, biological preparations for medical [ and veterinary ] purposes, diagnostic preparations for clinical or medical laboratory use; kits comprised principally of medical diagnostic assays for testing of bodily fluids; diagnostic testing kits containing peptide substrates used in analyzing and detecting certain proteins indicating onset of human joint inflammatory disease, for clinical or medical laboratory use; medical diagnostic test kits, comprised principally of test strips, for detection of autoimmune disease, medical diagnostic reagents and assays for testing of body fluids, drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; medical diagnostic enzyme linked immunoassays (ELISAs) for detection of autoimmune antibodies for clinical or medical laboratory useACTIVE—
010[ Medical apparatus and instruments, namely, apparatus for blood analysis; apparatus for clinical diagnosis ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 7, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 2, 2020ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jan 3, 2020INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Nov 18, 2019INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Nov 18, 2019INPCINVALIDATION PROCESSED—
Oct 27, 2019INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 27, 2019NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Feb 27, 201971AGREGISTERED-SEC.71 ACCEPTED—
Feb 21, 2019ES71TEAS SECTION 71 RECEIVED—
Dec 16, 2017REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Sep 28, 2017RNWLINTERNATIONAL REGISTRATION RENEWED—
Sep 4, 2015INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Aug 17, 2015INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Aug 17, 2015INPCINVALIDATION PROCESSED—
Jun 24, 2015INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Oct 24, 2014NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Oct 24, 2014C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Oct 24, 2014APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 16, 2014ES75TEAS SECTION 71 & 15 RECEIVED—
Mar 22, 2013NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 6, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 27, 2009FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 27, 2009FIMPFINAL DISPOSITION PROCESSED—
Mar 16, 2009FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 16, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 30, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 10, 2008NPUBNOTICE OF PUBLICATION—
Aug 25, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 25, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 22, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 22, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 22, 2008ALIEASSIGNED TO LIE—
Aug 15, 2008ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jul 29, 2008GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jul 29, 2008GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 29, 2008CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 16, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 16, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 16, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 6, 2008ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 6, 2008REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 20, 2007RFNTREFUSAL PROCESSED BY IB—
Nov 29, 2007RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 29, 2007RFRRREFUSAL PROCESSED BY MPU—
Nov 29, 2007RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 28, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 26, 2007DOCKASSIGNED TO EXAMINER—
Oct 12, 2007NWAPNEW APPLICATION ENTERED—
Oct 11, 2007REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance